Uniper reserves future SAF capacity from Syzygy’s NovaSAF platform

Verifying
  • Uniper reserved future SAF capacity from Syzygy Plasmonics’ NovaSAF platform.
  • NovaSAF-1 in Uruguay is approaching a final investment decision.
  • The agreement covers a dual-certified pathway for bio and RFNBO SAF.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.